Insider · CIK 0001817416
Kakkar Rahul
Reports to the SEC for 1 company · WATERTOWN, MA
Transactions
11
Companies
1
Filings
3
CIK
0001817416
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2021-04-01 | Pandion Therapeutics, Inc.U Disposition from Tender | −$840K |
| 2021-04-01 | Pandion Therapeutics, Inc.U Disposition from Tender | −$42.2M |
| 2021-04-01 | Pandion Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2021-04-01 | Pandion Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2021-02-08 | Pandion Therapeutics, Inc.Stock Option (right to buy)A Award | — |
| 2020-07-21 | Pandion Therapeutics, Inc.C Conversion | — |
| 2020-07-21 | Pandion Therapeutics, Inc.P Purchase | +$252K |
| 2020-07-21 | Pandion Therapeutics, Inc.Series B Preferred StockC Conversion | — |
| 2020-07-17 | Pandion Therapeutics, Inc.Stock Option (right to buy)A Award | — |
| 2020-07-17 | Pandion Therapeutics, Inc.Stock Option (right to buy)A Award | — |
| 2020-07-17 | Pandion Therapeutics, Inc.Stock Option (right to buy)A Award | — |
Recent filings
- 4Kakkar Rahul0000899243-21-014453SEC(opens sec.gov)
- 4Kakkar Rahul0000899243-21-005689SEC(opens sec.gov)
- 4Kakkar Rahul0000899243-20-019869SEC(opens sec.gov)
Companies
Address
C/O PANDION THERAPEUTICS, INC., 134 COOLIDGE AVENUE
WATERTOWN, MA, 02472